From development to manufacturing: ensuring quality and functionality in gene therapy
Sponsor
.png "https://www.bio-techne.com/instruments"){kind=logo}
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Achieving safe and effective transgene delivery is among the greatest challenges faced by gene therapy developers. The inherent complexity of viral vectors makes them difficult to characterize with consistency throughout development and manufacturing stages. One solution is leveraging automated solutions for quantitative viral characterization.
In this webinar, we will discuss precision analytical tools for critical quality attribute analysis to ensure safe, high quality, consistent, and efficacious therapies. These customizable, flexible, and fast assay and analytics systems provide the high-specificity, automation, and reliable results needed throughout the gene therapy development workflow.
- How to achieve rapid titer assessments using Simplex Plex technology
- How to harness imaged capillary electrophoresis for GMP-grade vector stability assessment and CE-SDS for capsid protein ratios and purity
- The advantages of protein expression potency assays with automated Simple Western platforms
SPEAKERS
You might also like
Global perspectives for cellular and gene therapy development and regulatory expectations: a conference report from the 2023 NIFDS-PMDA-USP Workshop for Advanced Therapies
Unveiling the critical pathways in AAV potency evaluation and future trends in gene therapy
De-risking cell therapy product development: strategies for commercial success
